ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,194 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentZugDalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug
DalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug Logo
Verified· 2 sources

DalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug

Summary

About the company

The core activity of DalCor Pharmaceuticals is the development and research of medicines for the treatment of cardiovascular diseases, particularly through the application of precision medicine. The company focuses on developing therapies to combat the world's largest health burden, cardiovascular diseases.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered4
Precision medicine for cardiovascular diseases
Precision medicine approach for post-acute coronary syndrome patients with the ADCY9 rs1967309 AA genotype, including dalcetrapib-based treatment concepts and companion genetic testing.
Dal-GenE-2 Clinical Trial
Phase III, double-blind, randomized placebo-controlled study evaluating dalcetrapib in 2,000 patients with recent acute coronary syndrome and the ADCY9 AA genotype.
dal-GenE Clinical Trial
Completed interventional cardiovascular outcomes trial assessing dalcetrapib in post-acute coronary syndrome patients with the ADCY9 rs1967309 AA genotype.
Dalcetrapib development
Development, manufacturing and marketing of dalcetrapib for patients with the ADCY9-AA genotype; clinical trial and accompanying genetic marker.
Comparisons

DalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank DalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug by reviews, experience and specialisations.

Is this your company?

Claim the company profile of DalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
Baarerstrasse 2
6302 Zug

At a glance

Legal form
Foreign branch
UID
CHE-441.445.979
Founded
2015 · 11 years
Last commercial register change
September 28, 2022
Employees
21 to 50

Knowledge

No knowledge articles yet

Once DalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

SI
Sarepta International Holdings GmbH
Zug
MO
Milestone One AG
Zug
NC
Novotech Clinical Research AG
Zug
GS
G&L Scientific (Schweiz) GmbH
Zug
TA
Trialize AG
Zug
AP
Aphaia Pharma AG
Zug
AP
A2A Pharma AG
Rotkreuz
AP
Alexion Pharma GmbH
Baar